Abrégé

Described herein are non-binding protein-drug conjugates having increased susceptibility to macropinocytosis by a population of cells in a macropinocytosis-positive disease state relative to a population of cells that are not in a macropinocytosis-positive disease state. The non-binding protein-drug conjugate can comprise a first portion comprising a non- binding protein scaffold that does not substantially bind to a cell surface, wherein the non- binding protein scaffold does not comprise a non-binding fibronectin type III (FN3) domain. A peptide linker can be coupled to and positioned between the first portion and a second portion, wherein the second portion can comprise a pharmaceutically active moiety or a diagnostic moiety.

Classes IPC  ?

• A61K 38/00 - Préparations médicinales contenant des peptides
• C07K 14/00 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés
• C08F 112/00 - Homopolymères de composés contenant un ou plusieurs radicaux aliphatiques non saturés, chaque radical ne contenant qu'une seule liaison double carbone-carbone et l'un au moins étant terminé par un noyau carbocyclique aromatique
• A61P 35/00 - Agents anticancéreux
• C08F 112/06 - Hydrocarbures